SC 13G/A: Replimune Group, Inc.
Ticker: REPL · Form: SC 13G/A · Filed: 2024-10-07T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Replimune Group, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000895421-24-000462 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000895421-24-000462 Filing Date 2024-10-07 Accepted 2024-10-07 16:38:31 Documents 1 Document Format Files Seq Description Document Type Size 1 MS AMENDMENT ReplimuneGroupIncREPL.txt SC 13G/A 10964 Complete submission text file 0000895421-24-000462.txt 12774 Mailing Address 1585 BROADWAY NEW YORK NY 10036 Business Address 1585 BROADWAY NEW YORK NY 10036 212-761-4000 MORGAN STANLEY (Filed by) CIK : 0000895421 (see all company filings) EIN. : 363145972 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance) Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. (Subject) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 Type: SC 13G/A | Act: 34 | File No.: 005-90574 | Film No.: 241358253 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)